Hetastarch
- Level
- Commodity
- Parent
- 51131900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131908This classification denotes a blood substitute, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 875Y4127EA. European Medicines Agency schedules Hetastarch in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14097MIG. Hetastarch generally arises in the molecular formula (C6H7O5)N.C2H5O.H. The term 'hetastarch' is an FDA designation. As of Q4 2014, HETASTARCH remains the US FDA Preferred Term for this commodity. Hetastarch bears US NLM identifiers UMLS ID C0020352 and NCI Concept Code C559. SMILES: CC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)OC)O)O)OC4C(C(C(C(O4)CO)OC)O)OCCO)O)O)O)O.
Same parent
Under 51131900 · 7Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.